Skip to main content
. 2021 May 5;195:29–43. doi: 10.1016/j.ymeth.2021.04.026

Fig. 4.

Fig. 4

SARS-CoV-2 Life Cycle and Therapeutic Approaches: Antiviral approaches (Entry/Fusion Inhibitors, Mpro inhibitors, PLpro inhibitors, and RdRp inhibitors); Immunomodulation approaches (Micronutrients and Nutritional Intervention, Immunomodulatory Steroids, Cytokine Based Interventions, Convalescent Plasma Therapy, Vaccines).